Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period

Area of Science:

• Pediatrics
• Infectious Diseases
• Pulmonology

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting multiple organs.
• Early diagnosis and intervention are crucial for managing CF.
• The role of prophylactic antibiotics in early CF management is an area of ongoing research.

Purpose of the Study:

• To evaluate the efficacy of continuous oral flucloxacillin prophylaxis versus episodic antimicrobial treatment in infants with cystic fibrosis.
• To assess the impact of early antibiotic strategy on clinical outcomes up to 24 months of age.

Main Methods:

• A randomized controlled trial involving 38 infants diagnosed with cystic fibrosis.
• Infants were assigned to either continuous flucloxacillin (250 mg/day) or episodic antibiotic treatment.
• Regular monitoring of anthropometric, dietary, clinical, and microbiological data by a nurse coordinator.

Main Results:

• No significant differences in baseline characteristics between the two groups.
• The episodic treatment group experienced more frequent cough and higher Staphylococcus aureus isolation rates.
• Infants receiving episodic treatment had more hospital admissions, higher admission rates, and longer hospital stays.

Conclusions:

• Continuous prophylactic flucloxacillin initiated early in cystic fibrosis management is associated with improved clinical progress.
• Early antibiotic prophylaxis may reduce the incidence of respiratory infections and hospitalizations in young children with CF.